FS-laer assisted intrastomal arcuate keratotomy a success

Article

Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.

Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.

Dr Theresa Ruckel et al., Department of Ophthalmology, Paracelsus Medical University, Salzburg, Austria, conducted an interventional case series on 16 patients with corneal astigmatism. All patients were treated with an FS laser for paired arcuate cuts on the steep axis completely placed within the corneal stroma.

Patients were followed for six postoperative months. Preoperative and postoperative assessments included corrected and uncorrected visual acuities, manifest refraction, corneal topography, endothelial cell count, and corneal pachymetry. All patients answered a subjective questionnaire to evaluate patient satisfaction.

There were no perforations and all incisions were positioned at the planned locations. Mean refractive cylinder, after six months of follow-up, was reduced significantly from 1.41 D ± 0.66 to 0.33 ± 0.42 D.

Mean topographic astigmatism was reduced significantly from 1.50 ± 0.47 D preoperatively to 0.63 ± 0.34 D at the six months follow-up. The questionnaire results revealed that patient satisfaction was very high.

The FS laser is able to successfully treat corneal astigmatism without the risks linked to incisions that penetrate the Bowman membrane.

Please visit the latest online issue of the Journal of Cataract and Refractive Surgery to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.